![Majid Mehtali](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Majid Mehtali
Nessuna posizione attualmente
Storia della carriera di Majid Mehtali
Precedenti posizioni note di Majid Mehtali
Società | Posizione | Inizio | Fine |
---|---|---|---|
Smol Therapeutics SAS | Presidente | - | 01/08/2013 |
VALNEVA | Direttore Tecnico/Scientifico/R&S | - | 01/08/2013 |
Vivalis Toyama Japan KK | Direttore/Membro del Consiglio | - | 01/08/2013 |
Vivalis SA
![]() Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Direttore/Membro del Consiglio | 19/07/2010 | 19/07/2010 |
Direttore Tecnico/Scientifico/R&S | 09/09/2009 | 28/05/2013 | |
Presidente | 16/07/2010 | 19/07/2010 |
Formazione di Majid Mehtali
University of Strasbourg | Doctorate Degree |
Statistiche
Distribuzione geografica
Francia | 5 |
Giappone | 2 |
Posizioni
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
President | 1 |
Settori
Health Technology | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
VALNEVA | Health Technology |
Aziende private | 3 |
---|---|
Vivalis SA
![]() Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Health Technology |
Smol Therapeutics SAS | |
Vivalis Toyama Japan KK |
- Borsa valori
- Insiders
- Majid Mehtali
- Esperienza